Medicare Enrolled
Dr. Laszlo Mechtler, MD
Neurology · Amherst, NY
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Mechtler from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Mechtler?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Mechtler
Dr. Laszlo Mechtler is a neurology specialist in Amherst, NY, with 20 years of NPI registration. Based on federal Medicare data, Dr. Mechtler performed 5,900 Medicare services across 1,493 unique beneficiaries.
Between the years covered by Open Payments, Dr. Mechtler received a total of $383,437 from 69 pharmaceutical and/or device companies across 1430 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Mechtler is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 12% volume in NY
$383,437 industry payments
Medicare Practice Summary
Medicare Utilization ↗5,900
Medicare services
Top 12% in NY for neurology
1,493
Unique beneficiaries
$32
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~295 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Gadobenate dimeglumine injection An injection of gadobenate dimeglumine, a contrast agent used to enhance imaging results. |
2,342 | $1 | $7 |
| Contrast dye for imaging (iodine-based) A contrast agent containing 300-399 mg/ml of iodine used to enhance imaging studies. It is administered per milliliter to improve the visibility of internal structures. |
2,150 | $0 | $1 |
| MRI scan of brain, without contrast A magnetic resonance imaging test of the brain that does not use contrast dye. This procedure creates detailed images of the brain's structure using magnetic fields and radio waves. |
323 | $143 | $605 |
| MRI of brain with and without contrast An MRI scan of the brain using contrast dye both before and after administration to provide detailed images of brain structures. |
193 | $237 | $1,285 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
152 | $93 | $150 |
| 3D radiographic procedure with computerized image postprocessing A radiographic imaging procedure that creates three-dimensional images using computerized processing of the captured data. |
107 | $57 | $185 |
| Ultrasound of head and neck blood flow, bilateral An ultrasound exam that uses sound waves to visualize and assess blood flow in the vessels of both the head and the neck. |
100 | $128 | $285 |
| MRI contrast dye injection (gadobutrol) | 98 | $0 | $2 |
| CT scan of head/brain, without contrast A CT scan uses X-rays to create detailed images of the head or brain without the use of contrast dye. |
94 | $79 | $271 |
| MRI of head blood vessels without contrast An MRI scan that creates detailed images of the blood vessels in the head without using contrast dye. |
94 | $157 | $615 |
| MRI of head blood vessels with and without contrast An MRI scan that uses contrast dye to create detailed images of the blood vessels in the head, performed both before and after the dye is administered. |
64 | $253 | $1,070 |
| 3D radiographic procedure A radiographic imaging technique that creates three-dimensional representations of internal structures. |
47 | $18 | $159 |
| MRI of neck blood vessels with and without contrast This procedure uses magnetic resonance imaging to create detailed pictures of the blood vessels in the neck. Images are taken both before and after the administration of a contrast dye to enhance visibility. |
31 | $265 | $1,070 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
19 | $121 | $225 |
| CT scan of head blood vessels with contrast A CT scan that uses contrast dye to create detailed images of the blood vessels in the head. |
17 | $178 | $675 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
16 | $123 | $200 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
15 | $65 | $100 |
| MRI of upper spine without contrast An MRI scan of the upper spinal canal that does not use contrast dye. This imaging test uses magnetic fields and radio waves to create detailed pictures of the spine. |
13 | $94 | $615 |
| Normal saline infusion, 250 cc Administration of 250 cubic centimeters of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater fluid. |
13 | $1 | $6 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
12 | $100 | $220 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.4% high complexity
93.5% medium
6.0% routine
Industry Payment Transparency
Open Payments through 2024 ↗$383,437
Total received (2018-2024)
Avg $54,777/year across 7 years
Top 3% in NY for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
69
Companies
1,430
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$325,092 (84.8%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$47,654 (12.4%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$10,691 (2.8%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$6,149
2023
$11,199
2022
$39,346
2021
$92,720
2020
$96,067
2019
$49,212
2018
$88,744
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Tonix Medicines, Inc.
$2,510
ABBVIE INC.
$1,151
PFIZER INC.
$555
Lundbeck LLC
$362
Lilly USA, LLC
$337
Currax Pharmaceuticals LLC
$231
UCB, Inc.
$192
SCILEX PHARMACEUTICALS INC.
$189
Teva Pharmaceuticals USA, Inc.
$183
Amgen Inc.
$79
Eisai Inc.
$68
IBSA Pharma Inc.
$51
Otsuka America Pharmaceutical, Inc.
$50
Novo Nordisk Inc
$43
Merck Sharp & Dohme LLC
$41
Octapharma USA, Inc.
$25
Genentech USA, Inc.
$21
Averitas Pharma Inc.
$21
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$21
Azurity Pharmaceuticals, Inc.
$17
Top 3 companies account for 68.6% of 2024 payments
All-time payments by company (2018-2024) ›
Amgen Inc.
$121,299
Allergan, Inc.
$59,391
Teva Pharmaceuticals USA, Inc.
$39,825
Lundbeck LLC
$28,913
IMPEL PHARMACEUTICALS INC.
$21,983
Biohaven Pharmaceuticals, Inc.
$21,384
Allergan Inc.
$20,045
ABBVIE INC.
$12,284
Promius Pharma LLC
$12,189
Avanir Pharmaceuticals, Inc.
$9,233
Supernus Pharmaceuticals, Inc.
$9,130
AbbVie Inc.
$8,737
Currax Pharmaceuticals LLC
$5,744
Biohaven Pharmaceutical Holding Company Ltd.
$3,658
Tonix Medicines, Inc.
$2,510
Lilly USA, LLC
$1,266
PFIZER INC.
$1,248
Novartis Pharmaceuticals Corporation
$948
UCB, Inc.
$447
ACADIA Pharmaceuticals Inc
$349
Upsher-Smith Laboratories LLC
$239
UPSHER-SMITH LABORATORIES LLC
$214
TONIX PHARMACEUTICALS, INC.
$198
SCILEX PHARMACEUTICALS INC.
$189
Abbott Laboratories
$169
SK Life Science, Inc.
$142
Novocure Inc.
$138
Arbor Pharmaceuticals, Inc.
$100
Otsuka America Pharmaceutical, Inc.
$93
Novo Nordisk Inc
$86
Azurity Pharmaceuticals, Inc.
$82
Merck Sharp & Dohme LLC
$71
Eisai Inc.
$68
ASSERTIO THERAPEUTICS, Inc.
$66
ARBOR PHARMACEUTICALS, INC.
$63
Endo Pharmaceuticals Inc.
$63
JAZZ PHARMACEUTICALS INC.
$57
Sunovion Pharmaceuticals Inc.
$53
IBSA Pharma Inc.
$51
Zyla Life Sciences
$43
Alkermes, Inc.
$42
Assertio Therapeutics, Inc.
$40
TerSera Therapeutics LLC
$38
Scilex Pharmaceuticals Inc.
$37
Janssen Biotech, Inc.
$36
Greenwich Biosciences, Inc.
$36
Alexion Pharmaceuticals, Inc.
$35
Ipsen Biopharmaceuticals, Inc
$34
IDORSIA PHARMACEUTICALS US INC
$34
Octapharma USA, Inc.
$25
Biogen, Inc.
$22
Janssen Pharmaceuticals, Inc
$22
Genentech USA, Inc.
$21
Axsome Therapeutics, Inc.
$21
Averitas Pharma Inc.
$21
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$21
Adamas Pharmaceuticals, Inc.
$20
Neurocrine Biosciences, Inc.
$19
Bausch Health US, LLC
$16
Daiichi Sankyo Inc.
$15
Shire North American Group Inc
$15
Melinta Therapeutics, Inc.
$15
Collegium Pharmaceutical, Inc.
$15
GE HealthCare
$14
AstraZeneca Pharmaceuticals LP
$14
BANNER LIFE SCIENCES, LLC
$13
Egalet US Inc
$12
Impax Laboratories, Inc.
$12
GE HEALTHCARE
$3
Top 3 companies account for 57.5% of all-time payments
Associated products mentioned in payments ›
ABILIFY ASIMTUFII · AFINITOR · AIMOVIG · AJOVY · AMYVID · APLENZIN · APTIOM · ARISTADA · AUSTEDO · Aimovig · Austedo XR · Auvelity · BAFIERTAM · BOTOX · BOTOX - MIGRAINE · BOTOX - NEUROLOGY · BOTOX THERAPEUTIC · Briviact · CAMBIA · CAPLYTA · COMIRNATY · CONTRAVE · COPAXONE · Cambia · DYSPORT · ELYXYB · ELYXYB - CELECOXIB · ELYXYB - celecoxib · EMGALITY · EPIDIOLEX · ERGOMAR · Epidiolex · Eprontia · GOCOVRI · Gliadel · Gralise · Horizant · INFINITY · INGREZZA · INJECTAFER · LATUDA · LYRICA · Leqembi · MOVANTIK · NASCOBAL · NORTHERA · NUEDEXTA · NUPLAZID · NURTEC ODT · Nayzilam · Nuedexta · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ONFI · ONZETRA XSAIL · ONZETRA Xsail · OXTELLAR XR · Ocrevus · Oncology · Optune · PANZYGA · PAXLOVID · PRIALT · Proclaim Family of SCS IPGs · QUDEXY XR Topiramate Extended Release Capsules · QULIPTA · QUTENZA · QUVIVIQ · REXULTI · REYVOW · RYTARY · SOLIRIS · SPRAVATO · SPRIX · STELARA · SUNOSI · Soliris · TOSYMRA · TOSYMRA SUMATRIPTAN NASAL SPRAY · TROKENDI XR · Tirosint · Tosymra Sumatriptan Nasal Spray · Trudhesa · UBRELVY · VYEPTI · VYVANSE · Vimpat · WELIREG · Wegovy · XCOPRI · ZAVZPRET · ZEMBRACE SYMTOUCH · ZEPBOUND · ZIPSOR · ZONISADE · ZTLido · Zembrace · Zembrace SymTouch Sumatriptan Injection
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (85%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in neurology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 3% for neurology in NY.
Geographic Context
Neurologists within 10 mi
73
Per 100K population
7.7
County median income
$71,175
Nearest hospital
UPSTATE NEW YORK VA HEALTHCARE SYSTEM (WESTERN NY VA HEALTHCARE SYSTEM)
2.5 mi
2.5 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Mechtler is a mixed practice specialist, with above-average Medicare volume (top 12% in NY), with speaking/promotional industry engagement in the top 3% of NY peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Mechtler experienced with gadobenate dimeglumine injection?
Based on Medicare claims data, Dr. Mechtler performed 2,342 gadobenate dimeglumine injection services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Mechtler receive payments from pharmaceutical companies?
Yes. Dr. Mechtler received a total of $383,437 from 69 companies across 1,430 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Mechtler's costs compare to other neurologists in Amherst?
Dr. Mechtler's average Medicare payment per service is $32. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Mechtler) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Neurology
Common procedures, typical costs, and what industry payments mean in neurology.
Same specialty & city
Neurologists in Amherst
Browse neurologists in Amherst ranked by procedure volume and transparency data.
Highest volume
Top Neurologists in NY
Neurologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Neurologists in NY
Which NY neurologists receive the most from drug and device companies.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
Allergan, Inc. Payments to Doctors
See all physicians who received payments from Allergan, Inc.
By company
Teva Pharmaceuticals USA, Inc. Payments to Doctors
See all physicians who received payments from Teva Pharmaceuticals USA, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology